At a glance
- Originator ALTANA Pharma; Cedona
- Developer Cedona
- Class Antihypertensives; Benzopyrans; Small molecules; Vasodilators
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 07 Aug 2007 Discontinued - Preclinical for Hypertension in Netherlands (unspecified route)
- 30 May 2001 Profile reviewed but no significant changes made
- 14 May 1997 No-Development-Reported for Hypertension in Netherlands (Unknown route)